vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $168.3M, roughly 1.6× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 0.7%, a 24.6% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs -16.5%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.

HCM vs PRK — Head-to-Head

Bigger by revenue
HCM
HCM
1.6× larger
HCM
$270.8M
$168.3M
PRK
Growing faster (revenue YoY)
PRK
PRK
+18.7% gap
PRK
2.2%
-16.5%
HCM
Higher net margin
PRK
PRK
24.6% more per $
PRK
25.3%
0.7%
HCM
More free cash flow
PRK
PRK
$188.6M more FCF
PRK
$191.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
PRK
PRK
Revenue
$270.8M
$168.3M
Net Profit
$2.0M
$42.6M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
25.3%
Revenue YoY
-16.5%
2.2%
Net Profit YoY
-83.6%
10.4%
EPS (diluted)
$0.00
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PRK
PRK
Q4 25
$270.8M
$168.3M
Q3 25
$169.5M
Q2 25
$277.7M
$168.7M
Q1 25
$324.5M
$157.9M
Q4 24
$164.7M
Q3 24
$170.3M
Q2 24
$305.7M
$157.7M
Q1 24
$152.8M
Net Profit
HCM
HCM
PRK
PRK
Q4 25
$2.0M
$42.6M
Q3 25
$47.2M
Q2 25
$455.0M
$48.1M
Q1 25
$11.9M
$42.2M
Q4 24
$38.6M
Q3 24
$38.2M
Q2 24
$25.8M
$39.4M
Q1 24
$35.2M
Gross Margin
HCM
HCM
PRK
PRK
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
PRK
PRK
Q4 25
-13.2%
Q3 25
34.3%
Q2 25
-1.3%
35.2%
Q1 25
-5.0%
32.4%
Q4 24
Q3 24
27.4%
Q2 24
-9.0%
30.6%
Q1 24
27.8%
Net Margin
HCM
HCM
PRK
PRK
Q4 25
0.7%
25.3%
Q3 25
27.8%
Q2 25
163.8%
28.5%
Q1 25
3.7%
26.7%
Q4 24
23.5%
Q3 24
22.4%
Q2 24
8.4%
25.0%
Q1 24
23.0%
EPS (diluted)
HCM
HCM
PRK
PRK
Q4 25
$0.00
$2.62
Q3 25
$2.92
Q2 25
$0.52
$2.97
Q1 25
$0.01
$2.60
Q4 24
$2.38
Q3 24
$2.35
Q2 24
$0.03
$2.42
Q1 24
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PRK
PRK
Cash + ST InvestmentsLiquidity on hand
$1.4B
$233.5M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.4B
Total Assets
$1.8B
$9.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PRK
PRK
Q4 25
$1.4B
$233.5M
Q3 25
$218.9M
Q2 25
$1.4B
$193.1M
Q1 25
$836.1M
$237.6M
Q4 24
$160.6M
Q3 24
$201.7M
Q2 24
$802.5M
$261.5M
Q1 24
$306.1M
Total Debt
HCM
HCM
PRK
PRK
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PRK
PRK
Q4 25
$1.2B
$1.4B
Q3 25
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$759.9M
$1.3B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$740.1M
$1.2B
Q1 24
$1.2B
Total Assets
HCM
HCM
PRK
PRK
Q4 25
$1.8B
$9.8B
Q3 25
$9.9B
Q2 25
$1.8B
$9.9B
Q1 25
$1.3B
$9.9B
Q4 24
$9.8B
Q3 24
$9.9B
Q2 24
$1.3B
$9.9B
Q1 24
$9.9B
Debt / Equity
HCM
HCM
PRK
PRK
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PRK
PRK
Operating Cash FlowLast quarter
$8.2M
$198.3M
Free Cash FlowOCF − Capex
$3.4M
$191.9M
FCF MarginFCF / Revenue
1.2%
114.1%
Capex IntensityCapex / Revenue
1.8%
3.8%
Cash ConversionOCF / Net Profit
4.21×
4.65×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$328.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PRK
PRK
Q4 25
$8.2M
$198.3M
Q3 25
$52.6M
Q2 25
$-72.9M
$49.7M
Q1 25
$40.3M
$37.9M
Q4 24
$178.8M
Q3 24
$43.8M
Q2 24
$-39.8M
$50.9M
Q1 24
$35.0M
Free Cash Flow
HCM
HCM
PRK
PRK
Q4 25
$3.4M
$191.9M
Q3 25
$51.1M
Q2 25
$-82.2M
$48.4M
Q1 25
$32.5M
$36.8M
Q4 24
$169.7M
Q3 24
$41.7M
Q2 24
$-49.9M
$49.0M
Q1 24
$31.9M
FCF Margin
HCM
HCM
PRK
PRK
Q4 25
1.2%
114.1%
Q3 25
30.1%
Q2 25
-29.6%
28.7%
Q1 25
10.0%
23.3%
Q4 24
103.0%
Q3 24
24.5%
Q2 24
-16.3%
31.1%
Q1 24
20.8%
Capex Intensity
HCM
HCM
PRK
PRK
Q4 25
1.8%
3.8%
Q3 25
0.9%
Q2 25
3.3%
0.8%
Q1 25
2.4%
0.7%
Q4 24
5.6%
Q3 24
1.2%
Q2 24
3.3%
1.2%
Q1 24
2.1%
Cash Conversion
HCM
HCM
PRK
PRK
Q4 25
4.21×
4.65×
Q3 25
1.11×
Q2 25
-0.16×
1.03×
Q1 25
3.38×
0.90×
Q4 24
4.63×
Q3 24
1.14×
Q2 24
-1.54×
1.29×
Q1 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons